HMOs Research
Specific HMOs 2’FL, 3’FL and 3’SL linked to infant brain development
Associations of Human Milk Oligosaccharides with Infant Brain Tissue Organization and Regional Blood Flow at 1 Month of Age.
Breakthrough Study Sheds Light On Bifidobacteria Impact on HMOs and Infant Gut Microbiome
Priority effects shape the structure of infant-type Bifidobacterium communities on human milk oligosaccharides
Largest review to date: Systematic analysis reveals 5 most prevalent HMOs including 2’-FL varies in breastmilk
Over 150 human milk oligosaccharides (HMOs) have been identified and their concentrations in human milk vary depending on Secretor and Lewis blood group status, environmental and geographical factors, lactation stage, gestational period, and maternal health
HMOs including 2′-FL support healthy gut microbial metabolite production
Human milk oligosaccharide-sharing by a consortium of infant derived Bifidobacterium species.
Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy
Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial
Gut simulation expands health benefits of HMOs in adults
The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.
HMO supplementation may boost bowel function and help adults with IBS: Study
Supplementation with the human milk oligosaccharides (HMOs) HMOs 2′-fucosyllactose (2’FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.
“First-of-its-kind” HMO supplement supports adults’ digestive and immune health
Standard Process has revealed GI Stability, a prebiotic wafer containing 2’-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO). Targeting adults, the wholefood supplement also contains Collinsonia root, beet and okra powder, and comes at a time when HMOs are being increasingly investigated for the health of both infants and adults. The company touts its “first-of-it-kind” supplement as being able to provide an immune system boost while stimulating the growth of favorable microbial bacteria
Associations of Human Milk Oligosaccharides with Infant Brain Tissue Organization and Regional Blood Flow at 1 Month of Age.
Priority effects shape the structure of infant-type Bifidobacterium communities on human milk oligosaccharides
Over 150 human milk oligosaccharides (HMOs) have been identified and their concentrations in human milk vary depending on Secretor and Lewis blood group status, environmental and geographical factors, lactation stage, gestational period, and maternal health
Human milk oligosaccharide-sharing by a consortium of infant derived Bifidobacterium species.
Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial
Paediatric experts have reviewed the nutritional constituents that have thus far been identified in human breast milk, along with their associated health benefits.
The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.
Supplementation with the human milk oligosaccharides (HMOs) HMOs 2′-fucosyllactose (2’FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.

